Net Assets for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's latest reported net assets is $6.32B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingNet AssetsSwitch metric
Latest period
$6.32B
YoY change
+22.7%
5Y CAGR
+19.0%
Peak year (2025)
$5.97B
Latest annual
$5.97B
Net Assets history chart for ResMed (RMD) from 1993 to 2025
Net Assets history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $5.97B | +22.7% | ||
| 2024 | $4.86B | +17.8% | ||
| 2023 | $4.13B | +22.9% | ||
| 2022 | $3.36B | +16.5% | ||
| 2021 | $2.89B | +15.6% | ||
| 2020 | $2.50B | +20.5% | ||
| 2019 | $2.07B | +0.6% | ||
| 2018 | $2.06B | +5.0% | ||
| 2017 | $1.96B | +15.7% | ||
| 2016 | $1.69B | +6.8% | ||
| 2015 | $1.59B | -9.7% | ||
| 2014 | $1.76B | +9.2% | ||
| 2013 | $1.61B | +0.2% | ||
| 2012 | $1.61B | -7.1% | ||
| 2011 | $1.73B | +34.4% | ||
| 2010 | $1.29B | +15.5% | ||
| 2009 | $1.12B | +3.1% | ||
| 2008 | $1.08B | +16.2% | ||
| 2007 | $931.22M | +26.2% | ||
| 2006 | $738.15M | +55.7% | ||
| 2005 | $474.06M | +31.1% | ||
| 2004 | $361.50M | +26.2% | ||
| 2003 | $286.43M | +48.5% | ||
| 2002 | $192.93M | +92.2% | ||
| 2001 | $100.37M | +6.8% | ||
| 2000 | $93.97M | +31.2% | ||
| 1999 | $71.60M | +40.9% | ||
| 1998 | $50.80M | +13.9% | ||
| 1997 | $44.60M | +14.4% | ||
| 1996 | $39.00M | +34.9% | ||
| 1995 | $28.90M | +416.1% | ||
| 1994 | $5.60M | +93.1% | ||
| 1993 | $2.90M | — |
Net Assets values are taken from ResMed's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
ResMed (RMD) most recent annual net assets stands at $5.97B (2025) – grew 22.7% year-over-year.
Looking at the 2020–2025 (5 years) stretch, ResMed net assets compounded at +19.0% per year, sustaining 10 straight years of year-over-year growth.
The dataset's maximum net assets sits at $5.97B (2025); the minimum reading of $2.90M dates to 1993.
ResMed (RMD) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $50.64B.
ResMed Net Assets by Year
ResMed Net Assets 2025: $5.97B
ResMed net assets in 2025 was $5.97B, grew 22.7% from 2024. This figure represents the highest annual value in the available history.
ResMed Net Assets 2024: $4.86B
ResMed net assets in 2024 was $4.86B, grew 17.8% from 2023.
ResMed Net Assets 2023: $4.13B
ResMed net assets in 2023 was $4.13B, grew 22.9% from 2022.
ResMed Net Assets 2022: $3.36B
ResMed net assets in 2022 was $3.36B, grew 16.5% from 2021.
ResMed Net Assets 2021: $2.89B
ResMed net assets in 2021 was $2.89B.
See more financial history for ResMed (RMD).
Sector peers — Net Assets
Companies in the same sector as ResMed, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is ResMed's net assets?
- Latest reported net assets for ResMed (RMD) is $6.32B (period ending December 31, 2025).
How has ResMed net assets changed year-over-year?
- ResMed (RMD) net assets changed +22.7% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed net assets?
- ResMed (RMD) net assets compound annual growth rate is +19.0% over the most recent 5 years available.
When did ResMed net assets hit its highest annual value?
- ResMed net assets reached its highest annual value of $5.97B in 2025.
What was ResMed net assets in 2024?
- ResMed (RMD) net assets in 2024 was $4.86B.
What was ResMed net assets in 2025?
- ResMed (RMD) net assets in 2025 was $5.97B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.